Collaborative projects with industry

In the past years, we had three Innosuisse grants in collaboration with Swiss companies. The projects dealt with commercial applications of the sybody technology.

F. Hoffmann-La Roche AG

Project title: SwissBody-enabled
small molecule drug discovery
Duration: 2014-2017
Direct contact: Roger Dawson

LeadXpro AG

Project title: Swissbodies for
antibiotics drug discovery
Duration: 2017-2020
Direct contact: Michael Hennig

Bühlmann Laboratories AG

Project title: Diagnose von Entzündungskrankheiten mittels neuartiger molekularer Binder
Duration: 2018-2021
Direct contact: Christian Gerhold